Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Sep;8(9):701-8.
doi: 10.1038/nrd2944. Epub 2009 Jul 17.

Lowering Industry Firewalls: Pre-Competitive Informatics Initiatives in Drug Discovery

Affiliations
Review

Lowering Industry Firewalls: Pre-Competitive Informatics Initiatives in Drug Discovery

Michael R Barnes et al. Nat Rev Drug Discov. .

Abstract

Pharmaceutical research and development is facing substantial challenges that have prompted the industry to shift funding from early- to late-stage projects. Among the effects is a major change in the attitude of many companies to their internal bioinformatics resources: the focus has moved from the vigorous pursuit of intellectual property towards exploration of pre-competitive cross-industry collaborations and engagement with the public domain. High-quality, open and accessible data are the foundation of pre-competitive research, and strong public-private partnerships have considerable potential to enhance public data resources, which would benefit everyone engaged in drug discovery. In this article, we discuss the background to these changes and propose new areas of collaboration in computational biology and chemistry between the public domain and the pharmaceutical industry.

Similar articles

See all similar articles

Cited by 16 articles

See all "Cited by" articles

References

    1. Pac Symp Biocomput. 2007;:304-15 - PubMed
    1. Nat Rev Drug Discov. 2008 Aug;7(8):632-3 - PubMed
    1. Nucleic Acids Res. 2009 Jan;37(Database issue):D1-4 - PubMed
    1. Drug Discov Today Technol. 2007 Winter;4(2):47-50 - PubMed
    1. Nature. 2007 Jun 14;447(7146):799-816 - PubMed

Substances

LinkOut - more resources

Feedback